Waco, TX, United States of America

Shen-En Chen

This inventor holds 1 USPTO granted patent. Top assignee: Baylor University. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shen-En Chen. Retrieved from https://idiyas.com/inventor/shen-en-chen-2k12dd73

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shen-En Chen in Cysteine Protease Inhibition

Introduction

Shen-En Chen is a notable inventor based in Waco, Texas. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for cysteine proteases. His work is crucial in addressing various protozoan infections and cancer-related issues.

Latest Patents

Shen-En Chen holds a patent titled "Inhibitors of cysteine proteases and methods of use thereof." This invention focuses on semicarbazone or thiosemicarbazone inhibitors of cysteine proteases. The methods described in the patent aim to prevent and treat protozoan infections such as trypanosomiasis, malaria, and leishmaniasis. Additionally, these compounds are useful in inhibiting cysteine proteases associated with carcinogenesis, including cathepsins B and L. He has 1 patent to his name.

Career Highlights

Shen-En Chen is affiliated with Baylor University, where he conducts research and collaborates with other scientists. His work has garnered attention for its potential applications in medicine and therapeutic interventions.

Collaborations

Some of his notable coworkers include Rogelio Siles and Ming Zhou. Their collaborative efforts contribute to advancing research in the field of cysteine protease inhibitors.

Conclusion

Shen-En Chen's innovative work in developing cysteine protease inhibitors showcases his commitment to addressing significant health challenges. His contributions are vital for future advancements in treating protozoan infections and cancer-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…